Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Russell Clayton is Chief Medical Officer at Larimar Therapeutics. OQRO lists 2 transactions filed with the SEC under this name, the latest on Jan 27, 2026, each linked to the official Form 4.
Chief Medical Officer
Disclosures on record
2
Companies involved
1
As of the latest filing on , Russell Clayton reported holding 71,443 shares of Larimar Therapeutics (LRMR), worth about $216K at the last close of $3 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Larimar Therapeutics LRMR | 71,443 | 71K direct | $3 | $216K | Jan 26, 2026 |
Is this Russell Clayton’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Larimar TherapeuticsLRMR
2 disclosures · Jan 2026
Jan 26, 202626Kdisclosed Jan 27
DetailsOfficial recordJan 26, 2026154Kdisclosed Jan 27
DetailsOfficial recordOn the latest SEC Form 4, dated Jan 26, 2026, Russell Clayton reported holding 71,443 shares of Larimar Therapeutics (LRMR). At the last close of $3 on Nov 13, 2026, that is about $216K. This is the stake disclosed in filings, not a net worth.